US Pharma MarketingWhen clinical AI gets real
Health tech is heading toward a future in which certain parts of medical care are delivered without any humans involved. Chats with startups Cadence and UpDoc reveal why, and how. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the…
We’re heading toward a future in which certain parts of medical care are delivered without any humans involved.
Cadence, which raised a $100 million Series C last week, is betting that it can make managing ...
Source: Endpoints News